It depends upon whether one wants to view the the system as being uniquely prejudiced against biomedical research into ME/CFS...
I don't think the system is 'uniquely' prejudiced against ME research, and neither, I think, does any campaigner I've encountered - everyone examining the evidence would have no choice but to agree that there are several other conditions that have suffered and do suffer from prejudice against biomedical research, and the degree of prejudice is a sliding scale.
However, it's a simple matter to look up the evidence in terms of US funding, where the league tables of CDC funding are readily available, and there you will find ME/CFS in somewhere around (very roughly from memory) 168th place out of 171 in terms of the CDC's absolute spend. When you then adjust those figures to reflect the number of sufferers, the disproportionality is magnified enormously, and when you also look at the severity and impact of some the other conditions in that class of barely-funded conditions, things look even worse. And then you remember that the vast majority of even that tiny pot is psychological research, and you do start to feel a bit hard-done-by. If you look at the other conditions whose funding is similarily grossly disproportionate to severity and numbers affected, you can't help but notice that they are nearly all conditions affecting women either exclusively or predominantly, and so while it's not an issue of unique prejudice, it's quite clearly one that can fairly be called systematic, with evidence to back up that assertion. Cort has written well on this subject, perhaps others here can look up and post some references, or perhaps you can research it yourself and provide an evidence-based analysis of funding levels.
...or whether one accepts that the system operates in an erratic fashion dictated by fashion, the appeal of novelty, and competing 'free masonaries' of medical specialisms.
Can I take it that when you say 'accepts' you don't mean to say you accept that this situation is acceptable, and that we should just shrug our shoulders and agree that it could not be otherwise, but rather you mean accept that these are the driving factors?
Are there any others? Do financial interests - the lure of lucrative payoffs and the priorities and prejudices of wealthy donors - play any role at all, would you say? And would you agree that in many areas those financial interests will tend to favour treatments that pay off for a lifetime rather than one-off treatments that pay off only once, or even solutions that identify and remove causes of illness? I would personally say that there is a public interest - decreasingly represented by the state's interest - in lowering ongoing cost of health service costs, but that this interest is in today's society increasingly outweighed by the growing power of corporate financial interests and their need to maintain and constantly increase ongoing revenue streams. And the evils of this situation do not require individuals to make unconscionable choices - this reality emerges automatically from spreadsheets comparing business cases and can emerge with little or no human intervention.
I find it all difficult to 'accept'. But in any case, there are surely other factors that can be added to your list, and prejudice and sexism are two that spring to mind.
I'm inclined to accept the latter larger world view mainly because the alternate solopsistic 'small world view' engenders a sense of M.E/CFS 'victimhood' which I don't think exists - the system creates many 'irrationalities' of which lack of consistent funding of biomedical research into ME/CFS is just one.
Here I do agree, in that it makes sense for beleaguered communities to identify suitable fellow-sufferers with whom they can make common cause. In which case, do you have any specific suggestions? But even if you do, abandoning the sense of 'victimhood' is not going to happen just because there are other people who are victims as well. And campaigning on specific issues - around a specific disease - is entirely legitimate, wouldn't you agree? - even if one tries to network in doing so.
Has the Psychiatry 'free masonary' profitted ? yes certainly but it is only because the system has randomly advantaged that specialism's interests over the last two decades.
I disagree with 'randomly'. Clearly there are systematic currents that can be identified, as I've explained above. And evidence is available here also: Prof Wessely himself stated the plan quite clearly in the recently-unlocked portions of the S-Files (i.e. the bits that aren't still subject to the Official Secrets Act): at the beginning of the two decades you mention, he stated clearly in his report that the agenda going forward was not to spend money seeking a cure and treating the illness, but to manage the costs and social impact...weasly though the wording is, the implication is clear and his 'prediction' has come true in exactly the situation you described. (Again, you can look this up or somebody else can dig out the relevant reference or quote and post it).
There is nothing 'random' about this. Prof Wessely's approach is one that saves vast sums of money for insurers, government, and funders of medical research, and once he popped up with his hypothesis that 'ME is merely a belief, a belief that one has ME', and fought the case for himself and his colleagues to proceed on that basis, it has always been an attractive and easy option for those making the decisions about how and where to spend money - it's a cheap option, in every sense of the word. Nothing random about that.
Does this analysis matter ? I think so because it suggests strategies for countering this particular 'irrationality' that are likely to be more successful than attacking the 'evil empire and its Sith Lords'. There are players within the system who are amenable to arguments of 'unfaireness' or 'imballance' - which is essentially what has happened within the MRC
I'm attracted by the strategy you point at because at this point we may agree - pragmatically, achieving change requires a simple, rational, evidence-based case of the unfairness and imbalance to be made to those who are amenable to that argument. That is indeed how we should approach the situation. But the fuller analysis does indeed matter, because in pursuing that strategy, we shouldn't be blind to the nature and strength of the forces that are not interested in being fair or balanced, are only interested in saving money in the short term, and who carry around irrational prejudices about the issues.
As to what has happened within the MRC, your summary seems accurate to me, but it's important to be aware of the deeper factors there too. The historical ME budget from the MRC has been stable at around 850k per annum for the last 10 years at least, 90% of it spent on psychosocial research, as dictated by the psychiatrists who consistently vote down the applications of people like Dr Kerr on the basis that they are using the wrong criteria (i.e. not using the psychiatrists own made-up criteria). This 850k per annum budget was, in the last financial year, reduced to around 100k, and soon after that shocking figure had been announced in response to parliamentary questions, an announcement was made, just in time for the next parliamentary debate on ME, of an exciting new one-off pot of 1.5m for ME research. Astute mathematicians couldn't help but notice that this was not an increase in funding (even though this point was remarked on nowhere but in blogs and forums of course) - the money has merely been held back for a year in order to be able to announce a large-sounding figure.
Slightly more promisingly, there is also a change in the structure for the allocation of that funding, with some good categories highlighted for research proposals - and that change is (I am told) almost entirely down to hard work and lobbying by the MEA, and small shifts in the politics of the MRC committee membership. The MEA appear to have won a small but possibly significant victory there, which should not be disrespected by anyone, and for which we should thank them...but just how significant that change of emphasis will prove, we will have to wait and see. When we see exactly how that 1.5m is going to be divided up, how worthwhile the successful research proposals look, and exactly who gets funded, we will be able to tell whether anything has actually changed here and whether we can expect the MRC-funded research to produce something useful for a change.
After more than two decades of waiting for the UK to begin conducting biomedical research into our illness[es], I don't think anybody will be counting their chickens here, nor whooping with delight. I'll save that for when the research funding is allocated along the rational lines Snow Leopard suggests above, and brought into line with other major diseases, at which point surely
some of the new 100m pot will be spent on something worthwhile...
- this may too late for Kerr's team - although even a chunk of MRC funding may not have been enough to keep a research team going for more than a year or two, and St Georges may still have taken a corporate decision to give space to a more 'sexy' specialism with funding guaranteed over a longer time scale, at the cost of losing Kerr's team.
Final note: your hypothesis as to the reasons for Kerr's loss of funding unfortunately does not seem fully explanatory of the available evidence, which says simply that Dr Kerr - perhaps the most well-known and popular UK-based medical researcher of ME over the past several years, and pretty much the only one ever to be funded by the MRC (I think he has been?) will never again be able to conduct research into ME, for reasons which have not been made public, and that he is very unhappy about this situation. If Dr Kerr cannot say why this is, then perhaps we will never know the reason, and perhaps it's best for him that we don't speculate or probe that question, but it's bound to make suspicious people more suspicious, and it's a great shame.